Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban Celis

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Science Advances|November 25, 2015
The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironmentMadhav D Sharma, Rahul Shinde, Tracy L McGaha, et al.
Cancer Immunology, Immunotherapy : CII|March 29, 2017
Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapyToshihiro Nagato, Takayuki Ohkuri, Kenzo Ohara, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 11, 2020
Role of dendritic cell-mediated immune response in oral homeostasis: A new mechanism of osteonecrosis of the jawRanya Elsayed, Zoya Kurago, Christopher W Cutler, et al.
Nature Communications|December 16, 2017
Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancerFilippo Veglia, Vladimir A Tyurin, Dariush Mohammadyani, et al.
Oncoimmunology|January 18, 2021
Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinomaRyusuke Hayashi, Toshihiro Nagato, Takumi Kumai, et al.
The Journal of Clinical Investigation|May 3, 2014
ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosisThomas Condamine, Vinit Kumar, Indu R Ramachandran, et al.
Cancer Science|May 19, 2021
A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapyAkemi Kosaka, Yuki Yajima, Mayumi Hatayama, et al.
Iscience|November 29, 2023
Enniatin A inhibits the chaperone Hsp90 and unleashes the immune system against triple-negative breast cancerNada H Eisa, Vincent M Crowley, Asif Elahi, et al.
Nature Medicine|July 13, 2010
Lipid accumulation and dendritic cell dysfunction in cancerDonna L Herber, Wei Cao, Yulia Nefedova, et al.
Cancer Cell|October 11, 2022
Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapyEvgenii N Tcyganov, Emilio Sanseviero, Douglas Marvel, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Science Advances|November 25, 2015
The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironmentMadhav D Sharma, Rahul Shinde, Tracy L McGaha, et al.
Cancer Immunology, Immunotherapy : CII|March 29, 2017
Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapyToshihiro Nagato, Takayuki Ohkuri, Kenzo Ohara, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 11, 2020
Role of dendritic cell-mediated immune response in oral homeostasis: A new mechanism of osteonecrosis of the jawRanya Elsayed, Zoya Kurago, Christopher W Cutler, et al.
Nature Communications|December 16, 2017
Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancerFilippo Veglia, Vladimir A Tyurin, Dariush Mohammadyani, et al.
Oncoimmunology|January 18, 2021
Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinomaRyusuke Hayashi, Toshihiro Nagato, Takumi Kumai, et al.
The Journal of Clinical Investigation|May 3, 2014
ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosisThomas Condamine, Vinit Kumar, Indu R Ramachandran, et al.
Cancer Science|May 19, 2021
A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapyAkemi Kosaka, Yuki Yajima, Mayumi Hatayama, et al.
Iscience|November 29, 2023
Enniatin A inhibits the chaperone Hsp90 and unleashes the immune system against triple-negative breast cancerNada H Eisa, Vincent M Crowley, Asif Elahi, et al.
Nature Medicine|July 13, 2010
Lipid accumulation and dendritic cell dysfunction in cancerDonna L Herber, Wei Cao, Yulia Nefedova, et al.
Cancer Cell|October 11, 2022
Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapyEvgenii N Tcyganov, Emilio Sanseviero, Douglas Marvel, et al.
Pageof 13